Lemaitre Vascular (LMAT) Raw Materials (2012 - 2026)

Lemaitre Vascular (LMAT) has reported Raw Materials for 15 consecutive years, with $20.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Raw Materials fell 7.44% year-over-year to $20.1 million in Q2 2026; TTM through Jun 2026 was $20.1 million, a 7.44% decrease from a year earlier, with the FY2025 full-year figure at $20.9 million, up 9.33% from the prior year.
• Raw Materials was $20.1 million for Q2 2026 at Lemaitre Vascular, down from $21.2 million in the prior quarter.
• Over five years, Raw Materials peaked at $21.7 million in Q2 2025 and troughed at $12.5 million in Q1 2022.
• A 5-year average of $18.4 million and a median of $19.1 million in 2023 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials jumped 186.37% in 2022 and dropped 7.44% in 2026, its largest moves.
• Over 5 years, Raw Materials stood at $14.9 million in 2022, then rose by 22.8% to $18.3 million in 2023, then increased by 4.23% to $19.1 million in 2024, then advanced by 9.33% to $20.9 million in 2025, then decreased by 3.77% to $20.1 million in 2026.
• The last three Raw Materials figures came in at $20.1 million (Q2 2026), $21.2 million (Q1 2026), and $20.9 million (Q4 2025), per Business Quant data.